These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26935787)

  • 21. Comparison of adverse drug reactions with donepezil versus memantine: analysis of the French Pharmacovigilance Database.
    Babai S; Auriche P; Le-Louët H
    Therapie; 2010; 65(3):255-9. PubMed ID: 20699079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unintentional Pediatric Cocaine Exposures Result in Worse Outcomes than Other Unintentional Pediatric Poisonings.
    Armenian P; Fleurat M; Mittendorf G; Olson KR
    J Emerg Med; 2017 Jun; 52(6):825-832. PubMed ID: 28408236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sticky situations: cyanoacrylate exposures reported to a poison control system.
    Carstairs SD; Koh C; Qian L; Qozi M; Seivard G; Cantrell FL
    Clin Toxicol (Phila); 2017 Nov; 55(9):1001-1003. PubMed ID: 28535077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
    Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
    Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy of dementia in elderly patients. A review.
    Olsen CE; Poulsen HD; Lublin HK
    Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective poison center review of varenicline-exposed patients.
    Kreshak AA; Clark AK; Clark RF; Ly BT; Cantrell FL
    Ann Pharmacother; 2009 Dec; 43(12):1986-91. PubMed ID: 19934384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serious adverse effects from single-use detergent sacs: report from a U.S. statewide poison control system.
    Huntington S; Heppner J; Vohra R; Mallios R; Geller RJ
    Clin Toxicol (Phila); 2014 Mar; 52(3):220-5. PubMed ID: 24580062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Minoxidil Exposures Reported to Texas Poison Centers.
    Forrester MB
    Pediatr Emerg Care; 2018 Jun; 34(6):413-416. PubMed ID: 29112111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.
    Bohlken J; Weber S; Rapp MA; Kostev K
    Int Psychogeriatr; 2015 Aug; 27(8):1335-42. PubMed ID: 25899936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997-2008.
    Armenian P; Kearney TE
    Clin Toxicol (Phila); 2014 Mar; 52(3):214-9. PubMed ID: 24528175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.
    Thornton SL; Darracq MA
    J Med Toxicol; 2020 Jan; 16(1):33-40. PubMed ID: 31410729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 46(3):687-93. PubMed ID: 26402513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole exposures reported to Texas poison control centers during 2002-2004.
    Forrester MB
    J Toxicol Environ Health A; 2006 Sep; 69(18):1719-26. PubMed ID: 16864422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective review of isolated gliptin-exposure cases reported to a state poison control system.
    Darracq MA; Toy JM; Chen T; Mo C; Cantrell FL
    Clin Toxicol (Phila); 2014 Mar; 52(3):226-30. PubMed ID: 24580063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
    Wu CY; Hu HY; Chow LH; Chou YJ; Huang N; Wang PN; Li CP
    PLoS One; 2015; 10(6):e0130993. PubMed ID: 26098910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.